These data were further enhanced by the increment of migration and invasion abilities of our PLCβ1-silenced cells, demonstrating that PLCβ1 silencing in glioblastoma seems to promote a shift towards a more aggressive cellular phenotype. The gene discussed is PLCB1; the disease is glioblastoma.